Enanta Pharmaceuticals, Inc. ENTA
10.37 USD -0.06 (-0.58%)
At closeNov 3, 2026, 4:01 PM EST
10.37 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
10.06 Day range 10.79
10.06 52-week range 17.15
- YTD
- -34.24%
- 1 year
- -4.16%
Analyst view
Consensus: buy
Buy
Price target (mean) 16.88 +62.7% upside
Now 10.37
- Target (low)
- 9.00
- Target (mean)
- 16.88
- Target (high)
- 27.00
Ratings (0m) 8 4 buy · 3 hold · 1 sell
- Strong buy2
- Buy2
- Hold3
- Sell0
- Strong sell1
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.27 | -1.38 – -1.16 | -1.58 | +19.8% | 17.67M | -1.9% | 4 |
| Next quarter | -1.41 | -1.45 – -1.32 | -1.47 | +4.4% | 16.42M | -3.7% | 4 |
| Current year | -5.11 | -5.67 – -4.70 | -5.48 | +6.7% | 72.47M | +7.1% | 4 |
| Next year | -5.25 | -8.67 – -2.95 | -5.11 | -2.7% | 69.79M | -3.7% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 26, 2024 | Baird | Maintained | Outperform | Outperform |
| Nov 26, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Oct 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 9, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Sep 27, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Aug 6, 2024 | JP Morgan | Maintained | Underweight | Underweight |
| Aug 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 7, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 7, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Feb 8, 2024 | JP Morgan | Maintained | Underweight | Underweight |
| Nov 22, 2023 | Oppenheimer | Maintained | Perform | Perform |
| Nov 21, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 21, 2023 | JMP Securities | Maintained | Outperform | Outperform |
| Oct 23, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 2, 2023 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Sep 19, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 9, 2023 | Oppenheimer | Maintained | Perform | Perform |
| Aug 8, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 8, 2023 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Aug 8, 2023 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Aug 8, 2023 | Jefferies | Downgrade | Buy | Hold |
| May 11, 2023 | Oppenheimer | Reiterated | Perform | Perform |
| May 9, 2023 | RBC Capital | Maintained | — | Sector Perform |
| May 9, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| May 9, 2023 | JMP Securities | Maintained | — | Outperform |
| Mar 22, 2023 | RBC Capital | Reiterated | — | Sector Perform |
| Feb 9, 2023 | SVB Leerink | Reiterated | — | Market Perform |
| Feb 8, 2023 | Piper Sandler | Maintained | — | Overweight |
| Feb 8, 2023 | JP Morgan | Maintained | — | Neutral |
| Jan 27, 2023 | SVB Leerink | Maintained | — | Market Perform |